227 related articles for article (PubMed ID: 22751954)
1. Fingolimod impedes Schwann cell-mediated myelination: implications for the treatment of immune neuropathies?
Köhne A; Stettner M; Jangouk P; Dehmel T; Hartung HP; Lehmann HC; Kieseier BC
Arch Neurol; 2012 Oct; 69(10):1280-9. PubMed ID: 22751954
[TBL] [Abstract][Full Text] [Related]
2. Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
Cui QL; Fang J; Kennedy TE; Almazan G; Antel JP
Glia; 2014 Aug; 62(8):1361-75. PubMed ID: 24810969
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions.
Van Doorn R; Van Horssen J; Verzijl D; Witte M; Ronken E; Van Het Hof B; Lakeman K; Dijkstra CD; Van Der Valk P; Reijerkerk A; Alewijnse AE; Peters SL; De Vries HE
Glia; 2010 Sep; 58(12):1465-76. PubMed ID: 20648639
[TBL] [Abstract][Full Text] [Related]
4. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors.
Mullershausen F; Craveiro LM; Shin Y; Cortes-Cros M; Bassilana F; Osinde M; Wishart WL; Guerini D; Thallmair M; Schwab ME; Sivasankaran R; Seuwen K; Dev KK
J Neurochem; 2007 Aug; 102(4):1151-61. PubMed ID: 17488279
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors.
Osinde M; Mullershausen F; Dev KK
Neuropharmacology; 2007 Apr; 52(5):1210-8. PubMed ID: 17379261
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo.
Hu Y; Lee X; Ji B; Guckian K; Apicco D; Pepinsky RB; Miller RH; Mi S
Mol Cell Neurosci; 2011 Sep; 48(1):72-81. PubMed ID: 21740973
[TBL] [Abstract][Full Text] [Related]
8. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A
Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487
[TBL] [Abstract][Full Text] [Related]
9. Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis.
Dev KK; Mullershausen F; Mattes H; Kuhn RR; Bilbe G; Hoyer D; Mir A
Pharmacol Ther; 2008 Jan; 117(1):77-93. PubMed ID: 17961662
[TBL] [Abstract][Full Text] [Related]
10. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis.
Lee CW; Choi JW; Chun J
Arch Pharm Res; 2010 Oct; 33(10):1567-74. PubMed ID: 21052934
[TBL] [Abstract][Full Text] [Related]
11. Non-phosphorylated FTY720 induces apoptosis of human microglia by activating SREBP2.
Yoshino T; Tabunoki H; Sugiyama S; Ishii K; Kim SU; Satoh J
Cell Mol Neurobiol; 2011 Oct; 31(7):1009-20. PubMed ID: 21519925
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology.
Brinkmann V
Pharmacol Ther; 2007 Jul; 115(1):84-105. PubMed ID: 17561264
[TBL] [Abstract][Full Text] [Related]
13. FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination.
Kipp M; Amor S
Mult Scler; 2012 Mar; 18(3):258-63. PubMed ID: 22383435
[TBL] [Abstract][Full Text] [Related]
14. Fingolimod phosphate promotes the neuroprotective effects of microglia.
Noda H; Takeuchi H; Mizuno T; Suzumura A
J Neuroimmunol; 2013 Mar; 256(1-2):13-8. PubMed ID: 23290828
[TBL] [Abstract][Full Text] [Related]
15. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
Krump-Konvalinkova V; Chwalla I; Siess W
Biochem Biophys Res Commun; 2008 Jun; 370(4):603-8. PubMed ID: 18402775
[TBL] [Abstract][Full Text] [Related]
16. The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro.
Liu Y; Jiang J; Xiao H; Wang X; Li Y; Gong Y; Huang Y
Int J Mol Med; 2012 Jul; 30(1):211-9. PubMed ID: 22576630
[TBL] [Abstract][Full Text] [Related]
17. Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.
Chiba K; Adachi K
Future Med Chem; 2012 Apr; 4(6):771-81. PubMed ID: 22530640
[TBL] [Abstract][Full Text] [Related]
18. Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype.
Heinen A; Beyer F; Tzekova N; Hartung HP; Küry P
Exp Neurol; 2015 Sep; 271():25-35. PubMed ID: 25957629
[TBL] [Abstract][Full Text] [Related]
19. IGF-1 stimulates de novo fatty acid biosynthesis by Schwann cells during myelination.
Liang G; Cline GW; Macica CM
Glia; 2007 Apr; 55(6):632-41. PubMed ID: 17299765
[TBL] [Abstract][Full Text] [Related]
20. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
Hasegawa Y; Suzuki H; Sozen T; Rolland W; Zhang JH
Stroke; 2010 Feb; 41(2):368-74. PubMed ID: 19940275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
